# CONTRAVE
> **NDA200063** · New Drug Application · Sponsor: NALPROPION · Approved 2014-09-10
## Drug
- **FDA Application Number:** NDA200063
- **Application type:** New Drug Application
- **Brand name:** CONTRAVE
- **Generic name:** NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE
- **Active ingredients:** BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NALPROPION
- **Manufacturer:** Nalpropion Pharmaceuticals LLC
- **First approval:** 2014-09-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200063)
---
*AI Analytics · CC0 1.0*